Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis
Molecular Oncology · 2025
DOI: 10.1002/1878-0261.70125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Francis Y He und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Program, Graduate School of Biomedical Science, Weill Cornell Medicine, New York, USA. Hauptthemen laut MEDLINE: Medulloblastoma, Meningeal Neoplasms, Cerebellar Neoplasms. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Medulloblastoma (MB) is the most common malignant tumor in the central nervous system in childhood and regularly metastasizes to the leptomeninges following radiation therapy. Using patient‐derived medulloblastoma models and genetically engineered mouse models, Nör et al. observed enhanced inflammation and infiltration of myeloid cells within the brain following irradiation. The authors identified inflammatory cytokines and the resulting breakdown of blood–brain barriers as the main culprits of MB leptomeningeal metastasis. This study demonstrated that targeting inflammation through the use of dexamethasone effectively reduced systemic inflammatory cytokines and the resulting radiation‐induced leptomeningeal metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroscience Program, Graduate School of Biomedical Science, Weill Cornell Medicine, New York, USA.
- Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA.
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, USA.
ORCID-Profile: Adrienne Boire
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
He, F. Y., & Boire, A. (2025). Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis. Molecular Oncology. https://doi.org/10.1002/1878-0261.70125
Vancouver
He FY, Boire A. Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis. Molecular Oncology. 2025. doi:10.1002/1878-0261.70125
BibTeX
@article{He2025,
author = {He, Francis Y and Boire, Adrienne},
title = {Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis},
journal = {Molecular Oncology},
year = {2025},
doi = {10.1002/1878-0261.70125}
}
EUVIMED